More than 50% of all people living with HIV worldwide are women. Globally, HIV/AIDS is the leading cause of death among women aged 15 to 44. The safe and effective methods of hormonal contraception are an essential component of preventive medical care in order to reduce maternal and infant mortality. However, there is limited knowledge regarding the effect of hormones on the rate of viral replication in HIV infection, especially non-B subtypes. The goal of the present work was to study in vitro how the female hormones β-estradiol and progesterone affect the replication of the HIV-1 subtypes A6, CRF02_AG, and B. The findings show that high doses of hormones enhanced the replication of HIV-1 sub-subtype A6 by an average of 1.75 times and the recombinant variant CRF02_AG by 1.4 times but did not affect the replication of HIV-1 subtype B. No difference was detected in the expression of CCR5 and CXCR4 co-receptors on the cell surface, either in the presence or absence of hormones. However, one of the reasons for the increased viral replication could be the modulated TLRs secretion, as it was found that high doses of estradiol and progesterone upregulated, to varying degrees, the expression of TLR2 and TLR9 genes in the PBMCs of female donors infected with HIV-1 sub-subtype A6.
Recent studies suggest that immune response to pathogens may vary depending on changes in hormone levels. Toll-like receptors (TLRs) are the key components of the innate immune system and play a crucial role in HIV infection. Given the significant genetic diversity of HIV-1, this study examined the effect of female sex hormones on the several TLR2, TLR4, and TLR9 expression in human peripheral blood mononuclear cells (PBLs) isolated from different female donors and infected with different variants of HIV-1 subtypes A6 and B. Thus, high doses of hormones upregulated the TLR2 and TLR9 expression in PBLs infected only with v1.A6, which also correlated with an increased viral load: by 3.8 times (p = 0.0033) when cells were treated with estradiol and by 4.4 times (p = 0.006) when treated with progesterone. Hormones did not modulate TLRs expression in the cells infected with subtype B, with the exception of one donor. In PBLs from this donor infected with the v1.B variant, hormones upregulated TLRs expression, which also correlated with the increased viral load (1.3-fold increase (p = 0.0036)). Hence, it was shown that gonadal steroids can play an important role in HIV-1 replication and immune response to a pathogen. Moreover, it was shown that different isolates of the same subtype may have distinct biological properties. The detected diversity in the TLRs expression in infected PBLs from different donors indicates that host genetics may also play an important role in HIV susceptibility.
Introduction. The urgent problem of modern medicine is the fight against acute respiratory viral infections (ARVI). To combat ARVI, drugs of wide antiviral potency are needed, as well as immunomodulating drugs. Such antiviral and immunomodulatory effects has sodium deoxyribonucleate (DNA-Na) and its complex with iron (DNA-Na-Fe) developed on the basis of double-stranded DNA of natural origin. Aim of the study: To assess antiviral and virucidal activity of DNA-Na and DNA-Na-Fe against viruses of different kingdoms and families. Materials and methods. Antiviral and virucidal activity of DNA-Na and DNA-Na-Fe was assessed in cell cultures infected with viruses. Results and discussion. DNA-Na and DNA-Na-Fe had antiviral activity against adenovirus at concentrations of 2501000 mcg/ml. Antiviral effect of both drugs was not detected in case of poliovirus. DNA-Na and DNA-Na-Fe had antiviral activity against coronavirus in all administration schemes. EC50 for DNA-Na ~ 2500 mcg/ml, for DNA-Na-Fe ~ 1000 mcg/ml. In cells treated with DNA-Na-Fe, secretion of following proinflammatory cytokines was detected: Interleukin (IL) 1, IL-2, IL-6, IL-18, interferon- (IFN-), IFN-, as well as anti-inflammatory cytokines: IL-4, IL-10, antagonist of IL-1 receptor. Evidently, DNA-Na and DNA-Na-Fe have antiviral effect, but mechanism of action does not seem to be associated with specific effect on viral replication. Presence of virucidal activity of drugs against representatives of Coronaviridae, Adenoviridae, Picornaviridae, Retroviridae, Herpesviridae in vitro test in range of 1.03.0 lg TCID50 was identified. Conclusion. Presence of simultaneous antiviral and virucidal activity of DNA-Na and DNA-Na-Fe against adeno- and coronaviruses shows their prospects for prevention and treatment of ARVI.
30 June 2026 in Journal of microbiology, epidemiology and immunobiology
Background. The most urgent problem of medicine is the fight against viral diseases. Preventive measures in the form of antiseptics with virucidal effect (VE) play an important role. Antimicrobial properties have been noted in compounds based on rare-earth metals. The aim of the study was to investigate the VE of lanthanum nitrate hexahydrate (LNH) and compositions based on it in order to establish the possibility of using them in the composition of topical antiseptics. Materials and methods. The VE of compounds was studied on the model of viruses: poliovirus, adenovirus, human immunodeficiency virus (HIV-1), herpes simplex virus (HSV-1). The VE was assessed by degree of reduction of virus titer in lg TCID50. The following compounds were studied: organic lanthanum composition (OLC), consisting of LNH (La(NO3)3·6H2O), triethylene glycol (TEG), ethyl carbitol (EC), glycerol, H2O and NaOH, as well as solutions of LNH in H2O and glycols: TEG, EC, 1,2-propylene glycol (PG), 1,3-butylene glycol (BG), polyethylene glycol-400 (PEG) and glycols themselves. Results. OLC reduced titers of poliovirus and adenovirus by 4.0-4.5 lg TCID50 in vitro, on surfaces by 4.0–5.0 lg TCID50 with disinfection time of 1–2 minutes. Components included in OLC reduced the titer of poliovirus by 3.1-4.0 lg TCID50. The reduction of HSV-1 titer of all compounds amounted to 4.0–4.3 lg TCID50. La(NO3)3·6H2O in PG, BG, PEG-400 and EC reduced HIV-1 titer by 4.8–5.3 lg TCID50 at pH below 4.62. The VE of LNH on HIV-1 on the surface is the reduction of the titer by 2.3–3.3 lg TCID50, depending on disinfection duration, the HSV-1 reduction titer amounted to 3.8 lg TCID50. Conclusion. For the first time it has been established that LNH and OLC possess a virucidal effect against both enveloped and non-enveloped viruses and can be considered as components of virucidal antiseptics. The VE of LNH without participation of additional compounds is very promising.